Welgene Biotech Co

Welgene Biotech Co Acquisitions (Net)

The Acquisitions (Net) of Welgene Biotech Co (6661.TWO) as of Oct 24, 2026 is -40.39 M TWD. In the previous year, Acquisitions (Net) was 33.73 M TWD — a change of -219.73% (lower).

Acquisitions (Net)

-40.39 MTWD

YoY

-219.73%

Last updated:

Acquisitions (Net) of Welgene Biotech Co is 2024 -40.39 M TWD. Acquisitions (Net) of Welgene Biotech Co was 2023 33.73 M TWD. It decreases by -219.73% lower compared to the previous year.

The Welgene Biotech Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
-24.45 M TWD
Jan 1, 2018
-12.65 M TWD
Jan 1, 2019
-16.76 M TWD
Jan 1, 2020
-3.69 M TWD
Jan 1, 2021
-5.96 M TWD
Jan 1, 2022
-41.13 M TWD
Jan 1, 2023
33.73 M TWD
Jan 1, 2024
-40.39 M TWD
The Welgene Biotech Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-40.39 MTWD-219.73%
33.73 MTWD-182.01%
-41.13 MTWD+589.97%
-5.96 MTWD+61.54%
-3.69 MTWD-77.98%
-16.76 MTWD+32.48%
-12.65 MTWD-48.26%
-24.45 MTWD-232.56%
18.44 MTWD-281.01%
-10.19 MTWD-104.66%
218.88 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Welgene Biotech Co Stock analysis

What does Welgene Biotech Co do? Welgene Biotech Co Ltd provides biotechnology services such as genetic testing, molecular diagnosis, and bioinformatics support to universities, hospitals, and pharmaceutical companies in Taipei City, Taiwan. The company specializes in DNA microarray, Next Generation Sequencing, and real-time quantitative PCR technologies, operating through two segments: Biotechnology Testing and Equipment Trading. Listed on 23 October 2017, it serves the local market with a focus on health care innovation. Welgene Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welgene Biotech Co stock

Acquisitions (Net) of Welgene Biotech Co is -40.39 M TWD in 2024.

Acquisitions (Net) of Welgene Biotech Co changed from 33.73 M TWD to -40.39 M TWD, representing a -219.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Welgene Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Welgene Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Welgene Biotech Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Welgene Biotech Co